V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 250002103 | 250005872 | null | null | null | 2019-11-15 | 2019-12-15 | Sunitinib | 02 | N | TRIAL UNSPECIFIED | 101790789 |
| 250002105 | 250005874 | null | 107 | null | 2019-03-27 | 2019-04-18 | null | 02 | null | TRIAL UNSPECIFIED | 100926058 |
| 250002111 | 250005879 | 1.72 | 79.4 | null | null | 2019-01-18 | Cisplatin + Radiotherapy + CISPLATIN | 02 | N | CISPLATIN | 100056306 |
| 250002113 | 250005880 | 1.82 | 70.9 | Palliative (P) | null | 2017-03-13 | AVELUMAB + AXITINIB | 02 | null | WT GUIDELINES CYCLOPHOS/DOXORUBICIN | 100126209 |
| 250002116 | 250005883 | null | null | Palliative (P) | null | 2020-08-14 | IPM | null | N | CAPECITABINE + OXALIPLATIN | 101526348 |
| 250002119 | 250005885 | null | null | Palliative (P) | null | 2018-10-27 | null | null | N | BACILLUS CALMETTE-GUERIN | 100796064 |
| 250002120 | 250005886 | null | null | Palliative (P) | 2019-10-10 | 2019-11-01 | null | 02 | null | ATEZOLIZUMAB | 101504562 |
| 250002121 | 250005887 | 1.78 | 85.9 | Curative (C) | null | 2017-07-03 | Dinutuximab Beta | 02 | N | CISPLATIN + FLUOROURACIL | 101421269 |
| 250002125 | 250005889 | 1.7 | 9.9 | Palliative (P) | null | 2019-12-17 | null | 01 | N | CARBOPLATIN + PACLITAXEL | 101525975 |
| 250002126 | 250005890 | null | null | null | null | 2016-12-12 | Eribulin | null | N | PACLITAXEL | 100989388 |
| 250002130 | 250005893 | 1.69 | 53.1 | Palliative (P) | 2020-10-25 | 2020-10-25 | CARBOPLATIN + PACLITAXEL | 02 | null | REGORAFENIB | 100761352 |
| 250002137 | 250005900 | 1.77 | 80 | Palliative (P) | null | 2019-12-20 | null | 99 | null | STS NON-RHABDO EPSSG 2005 IE | 100623950 |
| 250002145 | 250005904 | 1.1 | 87.3 | Palliative (P) | 2018-04-24 | 2018-05-08 | IMATINIB | 02 | null | TRIAL UNSPECIFIED | 101472386 |
| 250002146 | 250005905 | 1.72 | 11.2 | null | 2019-09-13 | 2019-09-23 | null | 02 | N | ENZALUTAMIDE | 100095753 |
| 250002148 | 250005906 | 1.6 | 82.6 | null | 2017-01-20 | 2017-04-02 | Cisplatin + Radiotherapy | 02 | null | CARBOPLATIN | 101776024 |
| 250002154 | 250005909 | null | null | null | null | 2017-01-01 | Dinutuximab Beta | null | N | NB HRNBL-1 CH14.18/CHO ONLY (TRIAL) | 100338236 |
| 250002158 | 250005911 | null | null | Neo-adjuvant (N) | 2017-10-24 | 2018-01-06 | BLEOMYCIN + CISPLATIN + VINCRISTINE | 02 | null | CARBOPLATIN + PEMBROLIZUMAB + PEMETREXED | 101285695 |
| 250002159 | 250005912 | 1.86 | 70 | null | 2018-04-06 | 2018-04-18 | Erlotinib | 02 | null | DOCETAXEL | 101834052 |
| 250002171 | 250005919 | null | null | null | null | 2019-05-03 | null | null | null | GEMCARBO | 100840939 |
| 250002182 | 250005923 | null | null | Curative (C) | null | 2018-10-06 | Cisplatin + Radiotherapy | null | N | CARBOPLATIN + FLUOROURACIL | 100436266 |
| 250002184 | 250005924 | 1.61 | 87.6 | Curative (C) | 2019-02-27 | 2019-02-28 | null | N | N | IMATINIB | 101605882 |
| 250002186 | 250005925 | 1.68 | 13.6 | null | 2018-12-17 | 2019-10-21 | CNS Low Grade Glioma Vinblastine | 02 | N | CETUXIMAB | 100759721 |
| 250002189 | 250005927 | 1.56 | 81.65 | Palliative (P) | 2017-03-05 | 2017-05-26 | null | 02 | N | WT GUIDELINES CYCLOPHOS/DOXORUBICIN | 100959745 |
| 250002193 | 250005928 | null | null | null | null | 2018-01-28 | Sunitinib | null | null | DACARBAZINE | 100279828 |
| 250002199 | 250005933 | null | null | Adjuvant (A) | null | 2013-04-04 | Eribulin | null | N | GEMCITABINE | 101830868 |
| 250002204 | 250005938 | 1.7 | 73 | Palliative (P) | 2018-03-15 | 2018-03-16 | Erlotinib | 02 | N | CARBOPLATIN + FLUOROURACIL | 101685596 |
| 250002209 | 250005941 | 1.5 | 0 | null | 2018-01-08 | 2018-01-08 | Docetaxel | 02 | N | CAPECITABINE + OXALIPLATIN | 100917404 |
| 250002212 | 250005942 | 1.79 | 83 | null | 2019-07-12 | 2019-07-12 | Capecitabine + Oxaliplatin 21day | 02 | N | CISPLATIN | 100197493 |
| 250002215 | 250005943 | 1.69 | 73.5 | Curative (C) | 2016-12-08 | 2018-09-15 | BUSULFAN + MELPHALAN | 02 | N | TRIAL UNSPECIFIED | 101174841 |
| 250002216 | 250005944 | 1.55 | 42.8 | null | 2018-08-06 | 2018-09-01 | NB Relapsed CCLG guidelines TVD | N | N | GEMCITABINE | 100432903 |
| 250002223 | 250005947 | 1.94 | 64.8 | Palliative (P) | 2018-01-14 | 2018-02-02 | Erlotinib | 01 | N | DACARBAZINE + GEMCITABINE | 101307704 |
| 250002227 | 250005948 | 1.67 | 72.6 | Neo-adjuvant (N) | 2019-02-11 | 2019-04-20 | Trial Unspecified | 02 | N | CETUXIMAB | 100248687 |
| 250002237 | 250005954 | 1.72 | 77.8 | Curative (C) | 2019-09-04 | 2019-09-07 | null | 02 | N | CARBOPLATIN + PEMETREXED | 100773104 |
| 250002238 | 250005955 | null | 82.5 | Curative (C) | 2020-04-10 | 2020-04-24 | PACLITAXEL | 02 | null | CAPECITABINE + OXALIPLATIN | 101471444 |
| 250002240 | 250005957 | 1.83 | 77 | null | 2017-05-09 | 2017-05-22 | null | 02 | N | CISPLATIN + RT | 100812506 |
| 250002246 | 250005961 | 1.6 | 57.4 | Palliative (P) | null | null | null | 02 | null | IPILIMUMAB + NIVOLUMAB | 100136221 |
| 250002249 | 250005963 | 1.84 | 89.7 | null | 2018-09-15 | 2019-06-12 | Cisplatin +Fluorouracil (3 wk) | 02 | N | PANITUMUMAB | 100640187 |
| 250002252 | 250005965 | 1.65 | 46 | Palliative (P) | null | 2019-10-03 | VINCRISTINE | 01 | N | CISPLATIN + FLUOROURACIL | 101497749 |
| 250002254 | 250005966 | 1.58 | 79 | null | 2020-05-01 | 2020-05-27 | null | 02 | N | ATEZOLIZUMAB | 100575057 |
| 250002255 | 250005967 | 1.51 | 87.9 | Palliative (P) | 2019-05-02 | 2019-05-25 | Paclitaxel 7 day | 02 | N | CETUXIMAB | 100518658 |
| 250002257 | 250005968 | 1.67 | 71.7 | null | 2019-04-30 | 2019-05-06 | DOXORUBICIN | 02 | N | TRIAL UNSPECIFIED | 101594205 |
| 250002261 | 250005969 | null | 81.7 | null | null | 2016-05-31 | Temozolomide + RT | 02 | N | DOXORUBICIN + IFOSFAMIDE | 100634456 |
| 250002262 | 250005970 | 1.69 | 71.7 | Palliative (P) | 2019-11-08 | 2019-11-21 | Trial Unspecified | 02 | N | ATEZOLIZUMAB | 100059687 |
| 250002263 | 250005971 | 1.6 | 66.2 | null | 2017-12-05 | 2017-12-12 | null | 02 | N | DOXORUBICIN | 100975579 |
| 250002266 | 250005972 | 1.8 | 88 | null | 2021-10-07 | 2021-10-10 | CARBOPLATIN + ETOPOSIDE | 02 | null | IMATINIB | 100799075 |
| 250002267 | 250005973 | 1.79 | 87.4 | Curative (C) | 2018-03-19 | 2018-04-23 | Atezolizumab | N | null | ATEZOLIZUMAB | 101699567 |
| 250002281 | 250005981 | 1.73 | 91.7 | 03 | 2017-01-10 | 2017-01-12 | null | 01 | N | FLUOROURACIL | 100043914 |
| 250002283 | 250005983 | 1.71 | 70.6 | Palliative (P) | null | 2019-03-13 | WT SIOP 2002 01 post op Carbo, Etop | 02 | N | CISPLATIN | 100663940 |
| 250002284 | 250005984 | 1.6 | 89.1 | Palliative (P) | null | 2018-12-16 | null | 02 | N | LIPOSOMAL DOXORUBICIN | 101166227 |
| 250002285 | 250005985 | 1.6 | 96.6 | Curative (C) | 2020-04-08 | 2020-05-19 | null | Y | null | CARBOPLATIN + PEMETREXED | 101253047 |